Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01204541 · ClinicalTrials.gov registry record
A Single-Center Pilot Study to Assess Macular Function
A clinical trial, sponsored by ORA.
- Completed
- Registry status
- 24
- Enrollment target
NCT01204541: Completed study, sponsored by ORA.
NCT01204541 is a clinical trial that has completed, run by ORA. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01204541 has completed, sponsored by ORA.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-09 |
| Est. Completion | 2010-10 |
What the finished NCT01204541 record still lists
NCT01204541 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01204541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01204541 about?
NCT01204541 is a clinical study titled "A Single-Center Pilot Study to Assess Macular Function". This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
What is the current status of trial NCT01204541?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2010-09. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT01204541?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia